Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review

Muula, Adamson S.; Ngulube, Thabale J.; Siziya, Seter; Makupe, Cecilia M.; Umar, Eric; Prozesky, Hans Walter; Wiysonge, Charles S.; Mataya, Ronald H.
January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p63
Academic Journal
Background: HIV and AIDS are significant and growing public health concerns in southern Africa. The majority of countries in the region have national adult HIV prevalence estimates exceeding 10 percent. The increasing availability of highly active antiretroviral therapy (HAART) has potential to mitigate the situation. There is however concern that women may experience more barriers in accessing treatment programs than men. Methods: A systematic review of the literature was carried out to describe the gender distribution of patients accessing highly active antiretroviral therapy (HAART) in Southern Africa. Data on number of patients on treatment, their mean or median age and gender were obtained and compared across studies and reports. Results: The median or mean age of patients in the studies ranged from 33 to 39 years. While female to male HIV infection prevalence ratios in the southern African countries ranged from 1.2:1 to 1.6:1, female to male ratios on HAART ranged from 0.8: 1 to 2.3: 1. The majority of the reports had female: male ratio in treatment exceeding 1.6. Overall, there were more females on HAART than there were males and this was not solely explained by the higher HIV prevalence among females compared to males. Conclusion: In most Southern African countries, proportionally more females are on HIV antiretroviral treatment than men, even when the higher HIV infection prevalence in females is accounted for. There is need to identify the factors that are facilitating women's accessibility to HIV treatment. As more patients access HAART in the region, it will be important to continue assessing the gender distribution of patients on HAART.


Related Articles

  • Stable Virologic Suppression during Raltegravir plus Atazanavir Dual-Therapy Taken Every other Day: A Case Report. Gentilotti, Elisa; De Nardo, Pasquale; Corpolongo, Angela; Tempestilli, Massimo; Oliva, Alessandra; Bellagamba, Rita; Tommasi, Chiara; Tumino, Nicola; Narciso, Pasquale; Nicastri, Emanuele // Journal of AIDS & Clinical Research;Special2012, Vol. 3 Issue S, Special section p1 

    Adherence to Highly Active Antiretroviral Therapy can be affected by a number of factors limiting the outcome of the treatment. We report the case of a 39 year-old HIV-HCV co-infected woman in stable virologic suppression and immune recovery during a raltegravir plus unboosted atazanavir...

  • Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs. Pradier, Christian; Carrieri, Patrizia; Bentz, Laurence; Spire, Bruno; Dellamonica, Pierre; Moreau, Joel; Moatti, Jean-Paul; Pradier, C; Carrieri, P; Bentz, L; Spire, B; Dellamonica, P; Moreau, J; Moatti, J P // International Journal of STD & AIDS;May2001, Vol. 12 Issue 5, p324 

    To evaluate the impact of injection drug users (IDUs) adherence on effectiveness of highly active antiretroviral therapy (HAART), repeated measures of plasma viral load and CD4+ counts before HAART initiation and at last visit in the cohort were studied. Data were collected by means of patient's...

  • Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. Protopopescu, Camelia; Roux, Perrine; Raffi, François; Reynes, Jacques; Dellamonica, Pierre; Spire, Bruno; Leport, Catherine; Carrier, Maria-Patrizia // Journal of Antimicrobial Chemotherapy (JAC);Sep2009, Vol. 64 Issue 3, p599 

    Objectives: The aim of this study was to identify factors associated with non-adherence over a 10 year follow-up of the APROCO-COPILOTE cohort during the maintenance phase of highly active antiretroviral therapy (HAART).

  • Getting personal about treating HIV. Neaton, James D.; Lane, H. Clifford // Nature Medicine;Apr2008, Vol. 14 Issue 4, p369 

    The article presents a study on personalized medicine such as highly active antiretroviral therapy (HAART) for HIV patients. Personalized medicine, which has been annunciated by the sequencing of the human genome, is a therapy based on patient-specific information. Results suggest that it is...

  • Antiretroviral therapy in a South African public health care setting -- facilitating and constraining factors. Ruud, Karine Wabø; Srinivas, Sunitha Chandrasekhar; Toverud, Else-Lydia // Southern Med Review;Sep2009, Vol. 2 Issue 2, p29 

    Objective: The objective of the study was to identify and document facilitating and constraining factors in the antiretroviral therapy (ART) programme in a public health care setting in the Eastern Cape, South Africa. Method: Observations for the study were carried out in a district hospital and...

  • Clinician-Assessed Depression and HAART Adherence in HIV-Infected Individuals in Methadone Maintenance Treatment. Gonzalez, Jeffrey S.; Psaros, Christina; Batchelder, Abigail; Applebaum, Allison; Newville, Howard; Safren, Steven A. // Annals of Behavioral Medicine;Aug2011, Vol. 42 Issue 1, p120 

    Background: The impact of measurement methods on the relationship between depression and HIV treatment adherence has not been adequately examined. Purpose: The purpose of this paper is to examine the relationship between clinician- and patient-rated depression and HIV medication adherence....

  • Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin. Palmieri, F.; Cicalini, S.; Froio, N.; Rizzi, E. B.; Goletti, D.; Festa, A.; Macrí, G.; Petrosillo, N. // International Journal of STD & AIDS;Jul2005, Vol. 16 Issue 7, p515 

    Extra-intestinal cryptosporidiosis, especially of the biliary and respiratory tract, is likely in the course of an intestinal involvement, whereas it is rare without such a localization. We report a case of pulmonary cryptosporidiosis without apparent intestinal involvement in an AIDS patient,...

  • Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda. Castelnuovo, B.; Babigumira, J.; Lamorde, M.; Muwanga, A.; Kambugu, A.; Colebunders, R. // International Journal of STD & AIDS;Feb2009, Vol. 20 Issue 2, p123 

    Antiretroviral treatment roll-out programmes in Africa often have difficulties to cope with the increasing number of clients. Based on the findings of a survey carried out in 2005 that showed long waiting times, innovative organizational changes (nurse visits and pharmacy-only refill visits)...

  • Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting. Montaner, Julio S.G.; Lima, Viviane D.; Harrigan, P. Richard; Lourenço, Lillian; Yip, Benita; Nosyk, Bohdan; Wood, Evan; Kerr, Thomas; Shannon, Kate; Moore, David; Hogg, Robert S.; Barrios, Rolando; Gilbert, Mark; Krajden, Mel; Gustafson, Reka; Daly, Patricia; Kendall, Perry // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Background: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, population-level sustainability of this strategy has not been characterized. Methods: We used population-level...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics